Stagecoach Theatre Arts plc
("Stagecoach Theatre Arts" or "the Company")
Director's dealing and issue of equity
Stagecoach Theatre Arts (AIM: STA) announces that Richard Dawson, Finance
Director, exercised options over 35,000 ordinary shares of 5p each in the
Company ("Ordinary Shares") on 5 August 2009 at an exercise price of 32.5 pence
per share. Application has been made for these shares to be admitted to trading
on AIM and this is expected to take place on 13 August 2009.
Following the exercise of these options, the resultant shareholding of Richard
Dawson will be 202,812 Ordinary Shares, representing 2.04 per cent. of the
Company's enlarged issued ordinary share capital.
7 August 2009
Enquiries:
Stagecoach Theatre Arts Tel: 01932 254 333
Richard Dawson, Finance Director & Investor Relations
Smith & Williamson Corporate Tel: 020 7131 4000
Finance Limited
Nominated Adviser & Joint Broker
David Jones / Barrie Newton / Charles Combe
Daniel Stewart & Company plc Tel: 020 7776 6550
Joint Broker
Paul Shackleton
Peckwater PR Tel: 07879 458 364
Public Relations tarquinedwards@btinternet.com
Tarquin Edwards
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.